JP2011093881A5 - - Google Patents

Download PDF

Info

Publication number
JP2011093881A5
JP2011093881A5 JP2010173298A JP2010173298A JP2011093881A5 JP 2011093881 A5 JP2011093881 A5 JP 2011093881A5 JP 2010173298 A JP2010173298 A JP 2010173298A JP 2010173298 A JP2010173298 A JP 2010173298A JP 2011093881 A5 JP2011093881 A5 JP 2011093881A5
Authority
JP
Japan
Prior art keywords
lecithin
pharmaceutical
nutrient composition
phospholipase
pms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010173298A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011093881A (ja
Filing date
Publication date
Priority claimed from US12/606,975 external-priority patent/US8399432B2/en
Application filed filed Critical
Publication of JP2011093881A publication Critical patent/JP2011093881A/ja
Publication of JP2011093881A5 publication Critical patent/JP2011093881A5/ja
Withdrawn legal-status Critical Current

Links

JP2010173298A 2009-10-27 2010-08-02 月経前症候群の症状を緩和するための治療組成物及び方法 Withdrawn JP2011093881A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/606,975 US8399432B2 (en) 2009-10-27 2009-10-27 Compositions and methods of treatment for alleviating premenstrual syndrome symptoms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014258058A Division JP5840284B2 (ja) 2009-10-27 2014-12-19 月経前症候群(pms)に付随する症状の緩和剤

Publications (2)

Publication Number Publication Date
JP2011093881A JP2011093881A (ja) 2011-05-12
JP2011093881A5 true JP2011093881A5 (https=) 2013-02-21

Family

ID=43610927

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010173298A Withdrawn JP2011093881A (ja) 2009-10-27 2010-08-02 月経前症候群の症状を緩和するための治療組成物及び方法
JP2014258058A Active JP5840284B2 (ja) 2009-10-27 2014-12-19 月経前症候群(pms)に付随する症状の緩和剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014258058A Active JP5840284B2 (ja) 2009-10-27 2014-12-19 月経前症候群(pms)に付随する症状の緩和剤

Country Status (5)

Country Link
US (1) US8399432B2 (https=)
EP (1) EP2322184B1 (https=)
JP (2) JP2011093881A (https=)
DK (1) DK2322184T3 (https=)
ES (1) ES2640009T3 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2769725T3 (en) 2013-02-22 2016-08-22 Lipogen Ltd PREPARATIONS FOR USE AT relief of symptoms associated with premenstrual syndrome and premenstrual dysphoric disorder
WO2018057737A1 (en) 2016-09-22 2018-03-29 Cash Alan B Method to alleviate the symptoms of pms

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3791951B2 (ja) 1995-11-08 2006-06-28 株式会社ヤクルト本社 多価不飽和脂肪酸含有ホスファチジルセリンを含む油脂組成物の製造方法
CA2382580C (en) * 1999-08-31 2009-05-19 Jenapharm Gmbh & Co. Kg Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
JP2002029967A (ja) * 2000-02-02 2002-01-29 Nisshin Oil Mills Ltd:The 月経前症候群症状緩和用食用油脂組成物
US7208180B2 (en) * 2000-05-08 2007-04-24 N.V. Nutricia Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
JP2002302441A (ja) * 2001-02-02 2002-10-18 Nisshin Oil Mills Ltd:The 月経前症候群症状緩和用組成物及び飲食物
JP2003055216A (ja) * 2001-08-03 2003-02-26 Nisshin Oillio Ltd 月経中症状緩和剤及びそれを含有する飲食物
NZ591627A (en) 2001-12-05 2012-09-28 Teva Womens Health Inc Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US6939877B2 (en) 2002-09-12 2005-09-06 Wyeth Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
IL158139A0 (en) * 2003-09-25 2004-09-27 Enzymotec Ltd Stabilized formulations of phosphatidyl serine
WO2005044176A2 (en) * 2003-11-10 2005-05-19 Lipogen Ltd. Compositions containing phosphatidic acid, methods of use thereof, methods of manufacture thereof, and articles of manufacture containing same
US20050196434A1 (en) * 2004-03-04 2005-09-08 Brierre Barbara T. Pharmaceutical composition and method for the transdermal delivery of magnesium
JP2005263668A (ja) * 2004-03-17 2005-09-29 Nof Corp ホスファチジルセリン含有水性組成物及び用途
JP2006131572A (ja) * 2004-11-08 2006-05-25 Tomiyoshi Murakawa 月経関連症状の緩和剤
JP2006131571A (ja) * 2004-11-08 2006-05-25 Nakai Kosan:Kk 月経関連症状の緩和剤
US8846338B2 (en) * 2008-08-07 2014-09-30 Lipogen Ltd. Processes for the preparation of phosphatides

Similar Documents

Publication Publication Date Title
He et al. Effect of dietary fat blend enriched in oleic or linoleic acid and monensin supplementation on dairy cattle performance, milk fatty acid profiles, and milk fat depression
WO2014020138A3 (en) Feed additive composition
NZ618734A (en) Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
NZ595987A (en) A novel formulation of diclofenac
WO2013153071A3 (en) A nutritional composition
WO2012110777A3 (en) Feed additive composition
NZ597193A (en) Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
WO2008058547A3 (en) Alpha-lactalbumin composition
NZ619076A (en) Isoxazolines as inhibitors of fatty acid amide hydrolase
NZ716730A (en) Methods, compositions, and devices for supplying dietary fatty acid needs
MX336347B (es) Metodo para atenuar los efectos adversos del farmaco usando los acidos grasos omega-3 como un vehiculo terapeutico parenteral del farmaco.
HK1210417A1 (en) Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders
KR101274543B1 (ko) 인간 아드레날린 β3 수용체 리간드, 이를 포함하는 식품 및 의약품
PH12014502802A1 (en) Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
WO2011065867A3 (en) Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis
JP2011093881A5 (https=)
WO2012064159A3 (ko) 항암용 조성물
MX2014001767A (es) Metodos para reducir sintomas o condiciones causados por estres.
WO2011126342A3 (ko) 대잎둥굴레 또는 층층갈고리둥굴레 추출물의 신규한 용도
KR101072300B1 (ko) 공액 리놀레인산 또는 그의 유도체를 함유하는 리포좀을 포함하는 사료 조성물
RU2013154564A (ru) Способы и композиции для стимуляции роста безжировой массы тела
EA201101638A1 (ru) Новые твердые формы {[(2s,5r,8s,11s)-5-бензил-11-(3-гуанидинопропил)-8-изопропил-7-метил-3,6,9,12,15-пентаоксо-1,4,7,10,13-пентаазациклопентадец-2-ил]уксусной кислоты} и способы их получения
RU2011130246A (ru) Фитоэстрогенные композиции для предотвращения или лечения симптомов, связанных с менопаузой
SI2200981T1 (sl) Novi derivati karbamoilglicina
JP2017109944A5 (https=)